The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2020
Filed:
Oct. 15, 2014
Centre National DE LA Recherche Scientifique (Cnrs), Paris, FR;
Universite DE Montpellier, Montpellier, FR;
University of Parma, Parma, IT;
Ecole Nationale Superieure DE Chimie, Montpellier, FR;
Gerard Cros, Montpellier, FR;
Alan Crozier, Scotland, GB;
Margherita Dall'asta, Parma, IT;
Daniele Del Rio, Parma, IT;
Richard Magous, Lunel, FR;
Catherine Oiry, Pignan, FR;
Centre National de la Recherche Scientifique (CNRS), Paris, FR;
Universite de Montpellier, Montpellier, FR;
University of Parma, Parma, IT;
Ecole Nationale Superieure de Chimie, Montpellier, FR;
Centre National de la Recherche Scientifique, Paris, FR;
Universite de Montpellier, Montpellier, FR;
Abstract
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.